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Abstract: Objectives: Celiac disease (CD) is an autoimmune disorder that can be divided into typical and atypical forms. 
Atypical forms can show extraintestinal manifestations among which oral signs are very frequent. Considering that the 
pathogenesis of CD is related to a positivity to specific HLA-DQB1 haplotypes, we tested whether the presence of the 
HLA-DQB1*02 allele could be a hypothetical cause of the development of oral manifestations. 
Subjects and Methods: For this study was been examined the oral condition of 98 Sardinian patients, all affected by CD 
and all on a gluten-free diet for at least 1 year. Then was been determined each patient’s HLA-DQB1 haplotype and  
compared these results with clinical information.  
Results: The statistical analysis evidenced that the absence of the HLA-DQB1*02 allele predisposes to oral manifestations 
such as dental enamel defects (DED) and recurrent aphthous stomatitis (RAS) (Pvalue=5.98x10
-05, OR = 0.23, CI:   
(0.10 - 0.45) per each copy of the HLA allele).  
Conclusions: These results showed that the presence of the HLA-DQB1*02 allele influences the development of oral 
signs in a dose-dependent manner and also how the HLA haplotype connected to oral signs could have a fundamental role 
for the diagnosis of atypical forms of CD. 
Keywords: Celiac disease, HLA, oral pathology. 
INTRODUCTION 
Celiac disease (CD) is an autoimmune disease linked to a 
permanent sensitivity to gliadin contained in alimentary glu-
ten [1, 2]. This condition determines chronic inflammation 
on intestinal mucous with consequent parietal injury [3]. The 
autoimmune response happens as a reaction against tissue 
transglutaminase autoantigen that principally damages the 
gastroenteric system determining global malabsorption with 
progressive flattening of the intestinal villi [4-6].  
Celiac disease can be distinguished into different clinical 
forms known as classical, atypical, subclinical and latent. 
The classical form is characterised by intestinal symptoms as 
chronic diarrhea, weight loss, growth deficit, vomiting; all 
other symptoms from other sites determine the atypical, sub-
clinical and latent forms [7, 8]. Atypical pattern may be often 
presents only by lesions in the oral mucosa or by defects in 
dental enamel [9]. 
CD is strictly linked to a genetic predisposition given by 
particular human leukocyte antigen (HLA) class II alleles, 
such as type 1 diabetes, rheumatoid arthritis, multiple sclero-
sis and Hashimoto’s thyroiditis [10, 11]. Among all HLA 
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codified antigens, 90% of celiac patients carry the HLA-
DQB1*0201 allele (DQ2 antigen) and, if this is absent, the 
HLA-DQB1*0302 allele (DQ8 antigen) [12, 13]. It is impor-
tant to highlight that this HLA molecule is almost always 
cis-encoded by the DRB1*0301-DQA1*0501- DQB1*0201 
haplotype, quite common in Sardinia (39% frequency) with 
one of the world’s highest frequencies [13-16]. In celiac dis-
ease we can identify an activation of T cells, linked to HLA 
expression, in the epithelium and lamina propria of the gut, 
which disappears after a gluten-free diet. Recent works have 
shown that T cells do not disappear in the oral mucosa of 
treated celiac patients due to a still unknown mechanism [17, 
18].  
 HLA typing is an important marker to confirm a diagno-
sis of CD, moreover today interest is increasing regarding 
different clinic forms of CD linked to different HLA-DQB1 
haplotypes [19]. 
Among all these clinical manifestations, the prevalence 
of CD is currently underestimated, since many atypical cases 
remain undiagnosed [20, 21]. The development of serious or 
even fatal complications (autoimmunity, cancers) requires 
the earliest possible diagnosis of CD [22]. This also explains 
the importance of a strict gluten-free diet for celiac patients 
who seem to be protected against long-term complications 
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Oral signs are most frequently CD symptoms, linked to 
atypical forms, and are represented principally by recurrent 
aphthous stomatitis (RAS) and dental enamel defects (DED) 
[6, 9, 25, 26]. The aim of this study is to investigate about a 
possible correlation between the presence of specific HLA 
alleles with the presence or absence of RAS and DED.
 
MATERIALS AND METHODS 
Subjects 
For this study were analysed 98 celiac patients (23 males 
and 75 females), with a medium age of 35.92 years (range 7 
- 77 years). All patients were typed for anti-gluten antibodies 
(AGA, both IgA and IgG) and antiendomysial antibody 
(EMA). Intestinal damage has been graded according to the 
Marsh classification (type 3, type 2 and type 1). In order to 
reduce possible confounding effects or intestinal damage due 
to diseases other than celiac disease, patients with the type 1 
and 2 of the classification were excluded before the study. 
For all participants the diagnosis of CD was stablished by 
demonstration of enteropathy with type 3 villous atrophy in a 
small bowel biopsy and all patients had been on a gluten-free 
diet for at least 1 year. Furthermore, all patients responded to 
a gluten-free diet, as evaluated upon further regular annual 
follow-ups. 
An anamnestic and diagnostic case study was compiled 
for each patient to indicate the past or present presence of 
celiac oral signs, such as RAS and DED [6, 25, 26]. DED 
were graded 0 to IV according to Aine’s classification [27-
29] (Table 1) while RAS linked to CD was determined by 
the investigation as the past presence of frequently aphtous 
lesions described by patients as the presence of one or more 
ulcers at the same time recurring at least 2 times a month, in 
the period before the gluten-free diet, and never more re-
turned after 1 month of diet. The presence of these lesions 
was verified by evaluating the medical records of first ad-
mission. 
At the time of examination, all participants were in-
formed about the research and its purpose and gave their 
informed consent in accordance with the ethical standards of 
the Helsinki Declaration of 1975. Oral brushing was subse-
quently carried out on all patients, obtaining a sample for 
DNA extraction allowing the determianation of the HLA-
DQB1 haplotype using the conventional PCR method [30].  
PCR Technique and Determination of HLA-DQB1   
Genotype 
To perform the PCR for each sample, a Kit formed from 
a pre-formed MIX and eight couples of primers was used. 
Positivity or negativity of amplification performed for each 
couple allows the HLA-DQB1 genotype to be determined
 
[25-26]. This set of primers will positively identify the HLA-
DQB1 alleles corresponding to the serologically defined 
series HLA-DQ2, DQ3, DQ4, DQ5, DQ6, DQ7, DQ8 and 
DQ9, thus all combinations of DQB1 can be readily identi-
fied. DQ4, DQ5 and DQ6 were uniquely identified, whereas 
the DQ2 specificity was amplified by three primer mixes, 
DQ7 and DQ9 specificities were amplified by two primer 
mixes, DQ3 and DQ8 specificities were amplified by four 
primer mixes. 
On the contrary, on examining the eight primer mixes 
with corresponding amplified DQB1 alleles, the first primer 
mix amplified allele group DQB1*05, the second amplified 
allele group DQB1*06, the third, the fourth and the sixth 
amplified allele group DQB1*02, the fourth, the fifth, sixth 
and seventh amplified allele group DQB1*03 and the eighth 
amplified allele group DQB1*04. 
For all the alleles, the reaction was performed in 10.08 μl 
reaction volumes using the mixture according to the manu-
facturer's instructions. The mixture contained 3 μl of master 
mix, 5 μl of DNAsi-RNAsi free water, 0.08 μl of Taq po-
lymerase and 2 μl of DNA suspension, this was put into a 
tube containing the lyophilized primer pair. The thermocy-
cler profile was as follows: an initial denaturation at 94° C 
for 2 min; 10 cycles consisting of 94°C for 10 sec and 65° C 
for 1 min and finally 20 cycles consisting of 94° C for 10 
sec, 61° C for 1 min and 72° C for 30 sec. PCR products 
were analysed by electrophoresis on an agarose gel. 
Statistical Analysis 
To test the relation between the HLA haplotype and the 
presence of oral signs, we used a logit regression model 
where the outcome variable represents the presence (or ab-
sence) of the specific oral sign to be tested (DED , RAS, or 
both). A variable was then coded with values 0, 1 or 2 if the 
individual carried no, one or two copies of the HLA-
DQB1*02 allele, respectively. 
RESULTS 
Among the 98 patients included in this study, 38.8% (38 
persons) were affected by RAS before the gluten-free diet 
and 28.6% (28 patients) presented DED. Grade I type enamel 
defects were the only diagnosed. In total 61.2% (60 patients) 
of the patients showed one or more oral signs (Fig. 1).  
The majority of the patients carried one (48.0%) or two 
(33.7%) copies of the HLA-DQB1*02 allele, whereas 18.3% 
did not carry this allele. Interestingly, we observed that most 
of the patients carrying one of two copies of the HLA-
DQB1*02 allele did not show DED, and this observation 
was statistically significant (P=0.0003, see Table 2). Simi-
larly, the presence of at least one copy of the HLA   
allele correlates with a lower frequency of RAS (P=0.002,  
Table 1.  Classification of Systemic Enamel Defects in Celiac 
Disease, (29) 
Grade I  Defects in colour of enamel: single or multiple 
cream, yellow or brown opacities 
Grade II  Slight structural defects: rough enamel surface,  
horizontal grooves, shallow pits 
Grade III  Evident strucutral defects: deep horizontal grooves, 
large vertical pits 
Grade IV  Severe structural defects: shape of the tooth may be 
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Fig. (1). Distribution of DED and RAS among the 98 examined patients. 
Table 2. This Table Summarizes the Distribution of the HLA-DBQ*02 Haplotype Among Individuals Affected by DED, or RAS, or 
by One of these Two. For Each Oral Sign Tested, We Reported the p-Value and the Odds Ratio for Each Copy of the HLA Allele 
Copies of the HLA-DBQ*02   N Affected  N Unaffected  Affected%  Unaffected%  OR 
(CI -2.5-97.5) 
Pvalue 
DED 
0         12  6  0.428  0.085     
1  12  35  0.428    0.500     
2 4  29  0.142  0.414     
       0.25  (  0.11-0.51)  0.0003 
RAS 
0         12  6  0.315   0.100     
1 19  28  0.500    0.467     
2  7  26  0.185     0.433     
       0.37  (0.18  -0.68)  0.002 
DED or RAS 
0 18  0  0.340  0.000     
1  24  23  0.453    0.676     
2 11  22  0.207    0.324     
       0.23  (0.10-  0.45)  5.98x10
-5 
 
see Table 2 ). The statistical evidence was stronger when 
considering both oral signs. Indeed, all individuals who did 
not carry a copy of the HLA-DQB1*02 allele presented RAS 
or DED (P=5.98x10
-5, see Table 2 and Fig. 2), while no ap-
preciable difference was observed between those carrying 
one or two copies.  
DISCUSSION 
For modern medicine, genetic screening is becoming 
more important thanks to major advances in research into 
pathology etiology. Nowadays HLA is one of the most stud-
ied genetic loci because it is linked to many genetic diseases; 
among these,celiac disease is an important candidate for pub-
lic health newborn genetic screening based on HLA-DQ al-
leles [31].  
Genetic screening on HLA locus linked to celiac devel-
opment will primarily eliminate the further need for the 60% 
of the population lacking the DQ2 and DQ8 antigens to un-
dergo serial autoantibody testing but the aim of this work 
was to show how HLA could be important not just for ob-
taining an “exclusion diagnosis” [32, 33]. 
In recent years, the increasing detection of atypical forms 
of CD, has made it necessary to find more precise early di-
agnostic methods that permit the underlying part of the “ce-
liac iceberg "to be discovered [21, 34]. In this study on 98 
CD patients from Sardinia we evaluated the possible rela-
tionship between the HLA haplotype and the development of 
oral diseases to verify the value of these oral signs as diag-
nostic instruments of CD. We observed that the absence of 
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at least RAS or DED, while no appreciable difference was 
observed between those carrying one or two copies. To ex-
plain these results, anaylsis on the binding capacity to the 
pocket of HLA-DQ2 or HLA-DQ8 molecules on antigen-
presenting cells [35] must be carried out. CD immunitary 
reactions are linked to the relationship established by this 
complex and CD4+ T cells causing tissue damage in the in-
testinal mucosa. This tissue damage seems to be correlated to 
an increasing presentation of gluten epitopes to T cells asso-
ciated to the presence of the HLA heterodimer DQB1*02 
which differ in their peptide binding affinity for gluten pep-
tides [36]. This data explain why DQ2 homozygosis in intes-
tinal mucosa is linked to a more marked intestinal flattening 
of the villi [13]; faced with these results we need to under-
stand why the oral mucosa seem to have opposite behaviour. 
This different response could be explained by the immu-
nological and histological differences between the small in-
testine and the gut. The pathological alterations linked to 
celiac disease are correlated to T-cell activity in the presence 
of gliadin-derived peptide. This mechanism is well studied in 
the small intestine, where lymphocytes induce mucosal dam-
age while the exact pathogenetic mechanism that leads to the 
development of lesions in the oral mucosa is still unknown.  
There are many hypotheses about the different responses 
of intestinal or oral mucosa. The existence of different gli-
adin peptides that could provoke an immunological reaction 
depending on different anatomic or histological areas, the 
activity of oral bacteria as first participants in the enzymatic 
degradation of gliadin or the histological differences 
between the intestinal mucosal epithelium, consisting of 
single layered cuboidal cells compared to the stratified 
epithelium of the oral mucosa, which could explain the 
different concentration of gliadin-derived peptide [37, 38]. 
More accurate estimation and confirmation of the effect of 
specific HLA alleles require further evaluation in a larger 
sampling paying particular attention to the possible interac-
tion of HLA loci with other genes (gene-gene interaction) 
[39]. Any possible further study could also focus on the ap-
plication of more rapid, though more expensive, methods to 
obtain the HLA haplotype such as PCR-realtime [40]. 
Overall, our results suggest that genetic predisposition at 
the HLA-DQB1 locus, influences the formation of celiac 
oral signs in CD and could become a fundamental test for 
recognising underlying celiac forms. In conclusion, further 
studies will be necessary to establish if the role of oral 
pathology can be significant in identifying latent and 
atypical forms of celiac disease. 
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